TrialsgrambetaRCTs are beautiful

COAPT

2018

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy

In 614 patients with HF and severe secondary mitral regurgitation, MitraClip plus GDMT reduced HF hospitalisation and all-cause mortality compared with GDMT alone.

Result

Efficacy: HF hospitalisation rateHR 0.53

Below 1 favours MitraClip plus GDMT, above 1 favours GDMT alone.

Event rates MitraClip plus GDMT 35.8 vs GDMT alone 67.9 per 100 patient-years

Also reported: Mortality 29.1 % vs 46.1 %.

Original publication
Subtopic
Mitral
Design
RCT, 2 yr
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
Stone GW, et al. N Engl J Med. 2018;379(24):2307-2318.doi 10.1056/NEJMoa1806640

Discussion & critique

MITRA-FR (same year, French) was negative; patient selection (disproportionate MR vs LV dilation) explains the divergence. Identifying COAPT-like anatomy is the practical takeaway.

Discussed in podcasts